rs398123401

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_201384.3(PLEC):​c.5930C>T​(p.Ala1977Val) variant causes a missense change. The variant allele was found at a frequency of 0.000111 in 1,584,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A1977A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 35)
Exomes 𝑓: 0.000099 ( 0 hom. )

Consequence

PLEC
NM_201384.3 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 4.68
Variant links:
Genes affected
PLEC (HGNC:9069): (plectin) Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.034488022).
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000224 (34/151778) while in subpopulation EAS AF= 0.000783 (4/5108). AF 95% confidence interval is 0.000359. There are 0 homozygotes in gnomad4. There are 20 alleles in male gnomad4 subpopulation. Median coverage is 35. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLECNM_201384.3 linkuse as main transcriptc.5930C>T p.Ala1977Val missense_variant 31/32 ENST00000345136.8
PLECNM_201378.4 linkuse as main transcriptc.5888C>T p.Ala1963Val missense_variant 31/32 ENST00000356346.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLECENST00000345136.8 linkuse as main transcriptc.5930C>T p.Ala1977Val missense_variant 31/321 NM_201384.3 Q15149-4
PLECENST00000356346.7 linkuse as main transcriptc.5888C>T p.Ala1963Val missense_variant 31/321 NM_201378.4 Q15149-9

Frequencies

GnomAD3 genomes
AF:
0.000218
AC:
33
AN:
151656
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.000509
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000394
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000781
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000946
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000212
AC:
44
AN:
207064
Hom.:
0
AF XY:
0.000190
AC XY:
22
AN XY:
115758
show subpopulations
Gnomad AFR exome
AF:
0.000508
Gnomad AMR exome
AF:
0.0000302
Gnomad ASJ exome
AF:
0.000658
Gnomad EAS exome
AF:
0.00145
Gnomad SAS exome
AF:
0.0000346
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000545
Gnomad OTH exome
AF:
0.000190
GnomAD4 exome
AF:
0.0000991
AC:
142
AN:
1432618
Hom.:
0
Cov.:
84
AF XY:
0.0000912
AC XY:
65
AN XY:
712478
show subpopulations
Gnomad4 AFR exome
AF:
0.00103
Gnomad4 AMR exome
AF:
0.0000228
Gnomad4 ASJ exome
AF:
0.000545
Gnomad4 EAS exome
AF:
0.000511
Gnomad4 SAS exome
AF:
0.0000589
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000236
Gnomad4 OTH exome
AF:
0.000655
GnomAD4 genome
AF:
0.000224
AC:
34
AN:
151778
Hom.:
0
Cov.:
35
AF XY:
0.000269
AC XY:
20
AN XY:
74222
show subpopulations
Gnomad4 AFR
AF:
0.000531
Gnomad4 AMR
AF:
0.000393
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000783
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000946
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000869
Hom.:
0
Bravo
AF:
0.000314
ExAC
AF:
0.000198
AC:
23
Asia WGS
AF:
0.000578
AC:
2
AN:
3472

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2022PLEC: BP4 -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityJun 15, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 27, 2013- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 18, 2021The c.6011C>T (p.A2004V) alteration is located in exon 32 (coding exon 31) of the PLEC gene. This alteration results from a C to T substitution at nucleotide position 6011, causing the alanine (A) at amino acid position 2004 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epidermolysis bullosa simplex, Ogna type;C2677349:Epidermolysis bullosa simplex 5C, with pyloric atresia;C2931072:Epidermolysis bullosa simplex 5B, with muscular dystrophy;C3150989:Autosomal recessive limb-girdle muscular dystrophy type 2Q;C4225309:Epidermolysis bullosa simplex with nail dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeDec 31, 2023This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2004 of the PLEC protein (p.Ala2004Val). This variant is present in population databases (rs398123401, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PLEC-related conditions. ClinVar contains an entry for this variant (Variation ID: 93069). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
.;.;.;.;T;.;.;.;.
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.10
N
LIST_S2
Uncertain
0.96
D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.034
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.97
.;.;.;.;L;.;.;.;.
MutationTaster
Benign
1.0
N;N;N;N;N;N;N;N;N
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.3
N;N;N;N;N;N;N;N;N
REVEL
Benign
0.18
Sift
Benign
0.18
T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.70
T;T;T;T;T;T;T;T;T
Polyphen
0.67
P;P;P;P;P;P;P;P;.
Vest4
0.28
MutPred
0.16
.;.;.;.;Gain of MoRF binding (P = 0.0753);.;.;.;.;
MVP
0.65
ClinPred
0.017
T
GERP RS
3.5
Varity_R
0.024
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs398123401; hg19: chr8-144998167; API